Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Takuto NosakaHidetaka MatsudaRyotaro SugataYu AkazawaKazuto TakahashiTatsushi NaitoMasahiro OhtaniKazuyuki KinoshitaTetsuya TsujikawaYoshitaka SatoYoshikazu MaedaHiroyasu TamamuraYasunari NakamotoPublished in: Current oncology (Toronto, Ont.) (2023)
The results indicated that PBT may show better benefits than TACE plus RFA therapy in terms of OS in patients with unresectable HCC by sparing the non-tumor liver tissues.